Epidermal EGFR Controls Cutaneous Host Defense and Prevents Inflammation
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epidermal EGFR Controls Cutaneous Host Defense and Prevents Inflammation
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 5, Issue 199, Pages 199ra111-199ra111
Publisher
American Association for the Advancement of Science (AAAS)
Online
2013-08-22
DOI
10.1126/scitranslmed.3005886
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genetic Ablation of Epidermal EGFR Reveals the Dynamic Origin of Adverse Effects of Anti-EGFR Therapy
- (2013) F. Mascia et al. Science Translational Medicine
- Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand–dependent terminal keratinocyte differentiation
- (2012) Claus-Werner Franzke et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mast Cell Stabilizer, Ketotifen, Prevents UV-Induced Wrinkle Formation
- (2012) Mi-Sun Kim et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Autocrine VEGF Signaling Synergizes with EGFR in Tumor Cells to Promote Epithelial Cancer Development
- (2010) Beate M. Lichtenberger et al. CELL
- Preliminary evidence for a role of mast cells in epidermal growth factor receptor inhibitor–induced pruritus
- (2010) Peter Arne Gerber et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Generation and validation of mice carrying a conditional allele of the epidermal growth factor receptor
- (2009) Tang-Cheng Lee et al. GENESIS
- Dermatologic Infections in Cancer Patients Treated With Epidermal Growth Factor Receptor Inhibitor Therapy
- (2009) R. E. Eilers et al. JNCI-Journal of the National Cancer Institute
- Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
- (2009) James A Bonner et al. LANCET ONCOLOGY
- RNase 7 Contributes to the Cutaneous Defense against Enterococcus faecium
- (2009) Bente Köten et al. PLoS One
- Staphylococcus aureus Bacteremia Secondary to Severe Erlotinib Skin Toxicity
- (2008) Tal Grenader et al. Clinical Lung Cancer
- Constitutive expression of CXCL14 in healthy human and murine epithelial tissues
- (2008) Simone Meuter et al. CYTOKINE
- Skin toxicity caused by EGFR antagonists-An autoinflammatory condition triggered by deregulated IL-1 signaling?
- (2008) Ulrich Rodeck JOURNAL OF CELLULAR PHYSIOLOGY
- The Koebner-Phenomenon in Epidermal Growth Factor Receptor Inhibitor–Induced Cutaneous Adverse Effects
- (2008) Peter Arne Gerber et al. JOURNAL OF CLINICAL ONCOLOGY
- Erlotinib-Induced Hair Alterations
- (2008) Peter Arne Gerber et al. NEW ENGLAND JOURNAL OF MEDICINE
- EGFR Antagonists in Cancer Treatment
- (2008) Fortunato Ciardiello et al. NEW ENGLAND JOURNAL OF MEDICINE
- High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: Results of a survey in EORTC institutes
- (2008) Christian Giro et al. RADIOTHERAPY AND ONCOLOGY
- The Epidermal Growth Factor Receptor System in Skin Repair and Inflammation
- (2007) Saveria Pastore et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search